Centessa (CNTA) is down -9.9%, or -$1.71 to $15.56.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa Pharmaceuticals: Promising Orexin Agonist Platform Justifies Buy Rating
- Centessa initiated with an Outperform at LifeSci Capital
- Centessa initiated with an Overweight at Wells Fargo
- Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
- Centessa resumed with an Outperform at Oppenheimer
